Alafi Capital is a private venture capital firm that has been active in
healthcare investing for over 25 years. Early and mid-stage investments in the
U.S. and Europe are considered, with emphasis on product-oriented biotechnology,
life science technologies, imaging and diagnostics, and medical devices.
Included among Alafi Capital’s past successes are Amgen, Biogen, Molecular
Devices, Tanox, Qiagen, Novocor, Oxford Glycosciences, and Applied Biosystems.
Kreatech Diagnostics, BV: Series B $2.7M (onbiovc.com)
Gene Security Network Completes $6M Series B Financing (reuters.com)
ARCXIS BIOTECHNOLOGIESÂ® SECURES SERIES B FINANCING (arcxis.com)
Isto Technolgies raise $8.8M (techstartupdatabase.blogspot.com)
Recent Incoming Links